New Drug Approvals


Home | Pages | Archives


Design, construction and start-up of a pilot plant for active pharmaceutical ingredients

June 12, 2014 6:31 am


Linde-KCA-Dresden built a pilot plant 16 times the size of the laboratory apparatus for Novo Nordisk A/S
Linde-KCA-Dresden built a pilot plant 16 times the size of the laboratory apparatus for Novo Nordisk A/S
The building layouts show different areas for the pilot plant, the utility systems and the technical rooms with hazardous and non-hazardous proof conditions (top). The engineering documents include the piping and instrumentation diagrams, the manufacturer vessel drawings as well as the 3D model with the isometric drawings of the pipes (bottom)
The building layouts show different areas for the pilot plant, the utility systems and the technical rooms with hazardous and non-hazardous proof conditions (top). The engineering documents include

The construction of a pilot plant constitutes an important milestone in the development cycle of a new active pharmaceutical ingredient. Pilot plants are used to gain the technological experience needed for the scale-up process and are required for producing sufficient quantities of the active pharmaceutical ingredient for clinical trials and other types of tests. As a result, even these testing facilities must comply with GMP regulations.

http://www.cpp-net.com/pharma/-/article/5829537/15910929/Challenging+task/

Posted by DR ANTHONY MELVIN CRASTO Ph.D

Categories: Drug discovery

Tags: , ,

Leave a Reply



Mobile Site | Full Site


Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.